| Filed On | Filing |
|---|---|
| 13 Oct 2026 |
Form 4: McFarlane Neil F., Director
Received 50,000 shares by exercise or conversion · Sold 20,000 shares ($225K) |
| 17 Aug 2026 |
Form 4: Thompson Rahsaan, Chief Legal & Compliance
Sold 42,666 shares ($475K) |
| 12 Aug 2026 |
Form 4: Watton Corey Michael, Director
Received 12,300 shares by exercise or conversion ($61.1K) · Sold 12,300 shares ($138K) |
| 23 Jun 2026 |
Form 4: Thompson Rahsaan, Chief Legal & Compliance
Received 66,667 shares by exercise or conversion · Sold 34,557 shares ($438K) |
| 18 Jun 2026 |
Form 4: Favorito Tamara A, Director
Granted 30,000 Stock Option (right to buy) |
| 18 Jun 2026 |
Form 4: Secor Alicia, Director
Granted 30,000 Stock Option (right to buy) |
| 18 Jun 2026 |
Form 4: Watton Corey Michael, Director
Granted 30,000 Stock Option (right to buy) |
| 18 Jun 2026 |
Form 4: Calder Douglas W, Director
Granted 30,000 Stock Option (right to buy) |
| 18 Jun 2026 |
Form 4: Anderson Thomas, Director
Granted 30,000 Stock Option (right to buy) |
| 18 Jun 2026 |
Form 4: Shih Alvin, Director
Granted 30,000 Stock Option (right to buy) |
| 29 May 2026 |
Form 4: Sangiovanni Timothy J., SVP, Finance & Corp Controller
Granted 40,000 Stock Option (right to buy) · Granted 20,000 Restricted Stock Unit |
| 13 May 2026 |
Form 4: Thompson Rahsaan, Chief Legal & Compliance
Sold 1,794 shares ($20.3K) |
| 26 Mar 2026 |
Form 4: Bode John B, Director
Received 78,400 shares by exercise or conversion ($387K) |
| 19 Mar 2026 |
Form 4: Renz Justin A, CFO
Granted 300,000 Stock Option (right to buy) |
| 10 Feb 2026 |
Form 4: McFarlane Neil F., Director
Received 37,500 shares by exercise or conversion · Sold 14,625 shares ($125K) |
| 04 Feb 2026 |
Form 4: Schafer Joshua, CCO
Sold 10,500 shares ($96.5K) |
| 04 Feb 2026 |
Form 4: Sangiovanni Timothy J., SVP, Finance & Corp Controller
Sold 3,000 shares ($27.5K) |
| 02 Feb 2026 |
Form 4: Thompson Rahsaan, Chief Legal & Compliance
Granted 37,500 Restricted Stock Unit · Granted 75,000 Stock Option (right to buy) · Received 11,333 shares by exercise or conversion · 1 more |
| 02 Feb 2026 |
Form 4: Quartel Adrian W, Chief Medical Officer
Granted 37,500 Restricted Stock Unit · Granted 75,000 Stock Option (right to buy) · Received 11,333 shares by exercise or conversion · 1 more |
| 02 Feb 2026 |
Form 4: Schafer Joshua, CCO
Granted 37,500 Restricted Stock Unit · Granted 75,000 Stock Option (right to buy) · Received 11,333 shares by exercise or conversion · 2 more |
Loading...